{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:34:59Z","timestamp":1761284099433,"version":"build-2065373602"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7244384"],"award-info":[{"award-number":["7244384"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-134"],"award-info":[{"award-number":["2022-PUMCH-B-134"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00277-025-06589-3","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T04:11:09Z","timestamp":1756959069000},"page":"4701-4711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating genomic and transcriptome features for characterization and prognostic prediction of angioimmunoblastic T-cell lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Chong","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congwei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"20","key":"6589_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"key":"6589_CR2","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361\u20131392","journal-title":"Blood"},{"issue":"25","key":"6589_CR3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol"},{"issue":"3","key":"6589_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.2020010387","volume":"138","author":"RH Advani","year":"2021","unstructured":"Advani RH, Skrypets T, Civallero M et al (2021) Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project. Blood 138(3):213\u2013220","journal-title":"Blood"},{"issue":"11","key":"6589_CR5","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1002\/cam4.3037","volume":"9","author":"W Liu","year":"2020","unstructured":"Liu W, Ji X, Song Y et al (2020) Improving survival of 3760 patients with lymphoma: experience of an academic center over two decades. Cancer Med 9(11):3765\u20133774","journal-title":"Cancer Med"},{"issue":"2","key":"6589_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M et al (2013) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol 31(2):240\u2013246","journal-title":"J Clin Oncol"},{"issue":"4","key":"6589_CR7","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1002\/cam4.5248","volume":"12","author":"C Wei","year":"2023","unstructured":"Wei C, Li W, Qin L et al (2023) Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T-cell lymphoma in China. Cancer Med 12(4):3987\u20133998","journal-title":"Cancer Med"},{"issue":"11","key":"6589_CR8","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L de Leval","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C et al (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109(11):4952\u20134963","journal-title":"Blood"},{"issue":"5","key":"6589_CR9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, International Peripheral T-Cell Lymphoma Project et al (2010) Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115(5):1026\u201336","journal-title":"Blood"},{"issue":"19","key":"6589_CR10","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C, Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project et al (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood. 123(19):2915\u201323","journal-title":"Blood."},{"issue":"9","key":"6589_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide O, Weigert O, Lane AA et al (2014) A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123(9):1293\u20131296","journal-title":"Blood"},{"issue":"4","key":"6589_CR12","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E et al (2017) Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica 102(4):e148\u2013e151","journal-title":"Haematologica"},{"issue":"21","key":"6589_CR13","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1182\/blood-2018-04-840538","volume":"132","author":"F Lemonnier","year":"2018","unstructured":"Lemonnier F, Dupuis J, Sujobert P et al (2018) Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. Blood 132(21):2305\u20132309","journal-title":"Blood"},{"issue":"16","key":"6589_CR14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1182\/blood.2020009004","volume":"137","author":"L Falchi","year":"2021","unstructured":"Falchi L, Ma H, Klein S et al (2021) Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study. Blood 137(16):2161\u20132170","journal-title":"Blood"},{"issue":"18","key":"6589_CR15","first-page":"2194","volume":"141","author":"J Ruan","year":"2023","unstructured":"Ruan J, Moskowitz A, Mehta-Shah N et al (2023) Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood 141(18):2194\u20132205","journal-title":"Blood"},{"issue":"1","key":"6589_CR16","doi-asserted-by":"publisher","first-page":"e1491","DOI":"10.1002\/ctm2.1491","volume":"14","author":"C Wei","year":"2024","unstructured":"Wei C, Wang W, Li W et al (2024) Mutations of epigenetic genes and correlation with treatment response in peripheral T-cell lymphoma. Clin Transl Med 14(1):e1491","journal-title":"Clin Transl Med"},{"issue":"3","key":"6589_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.20892\/j.issn.2095-3941.2020.0413","volume":"18","author":"W Zhang","year":"2021","unstructured":"Zhang W, Su L, Liu L et al (2021) The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b\/2 study. Cancer Biol Med 18(3):841\u2013848","journal-title":"Cancer Biol Med"},{"issue":"Supplement 1","key":"6589_CR18","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1182\/blood-2022-157899","volume":"140","author":"W Chong","year":"2022","unstructured":"Chong W, Yan Z, Jian L et al (2022) A multicenter, phase III study of chidamide, azacitidine combined with CHOP versus CHOP in patients with untreated peripheral T-Cell lymphoma. Blood 140(Supplement 1):6567\u20136568","journal-title":"Blood"},{"issue":"27","key":"6589_CR19","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068","journal-title":"J Clin Oncol"},{"key":"6589_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA (2018) Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol 1711:243\u2013259","journal-title":"Methods Mol Biol"},{"issue":"4","key":"6589_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M et al (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39(4):782\u2013795","journal-title":"Immunity"},{"issue":"10","key":"6589_CR22","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba S, Sakata-Yanagimoto M (2020) Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia 34(10):2592\u20132606","journal-title":"Leukemia"},{"issue":"5","key":"6589_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1182\/bloodadvances.2019001114","volume":"4","author":"M Witalis","year":"2020","unstructured":"Witalis M, Chang J, Zhong MC et al (2020) Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk. Blood Adv 4(5):868\u2013879","journal-title":"Blood Adv"},{"issue":"10","key":"6589_CR24","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3324\/haematol.2011.061507","volume":"97","author":"MH Delfau-Larue","year":"2012","unstructured":"Delfau-Larue MH, de Leval L, Joly B et al (2012) Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. Haematologica 97(10):1594\u2013602","journal-title":"Haematologica"},{"issue":"2","key":"6589_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3324\/haematol.2014.113472","volume":"100","author":"S Riihij\u00e4rvi","year":"2015","unstructured":"Riihij\u00e4rvi S, Fiskvik I, Taskinen M et al (2015) Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial. Haematologica 100(2):238\u2013245","journal-title":"Haematologica"},{"issue":"2","key":"6589_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/hon.2142","volume":"33","author":"F Marchesi","year":"2015","unstructured":"Marchesi F, Cirillo M, Bianchi A et al (2015) High density of CD68+\/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma. Hematol Oncol 33(2):110\u2013112","journal-title":"Hematol Oncol"},{"issue":"4","key":"6589_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1440-1827.2010.02514.x","volume":"60","author":"D Niino","year":"2010","unstructured":"Niino D, Komohara Y, Murayama T et al (2010) Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathol Int 60(4):278\u2013283","journal-title":"Pathol Int"},{"issue":"5","key":"6589_CR28","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41375-025-02563-0","volume":"39","author":"Y Suehara","year":"2025","unstructured":"Suehara Y, Sakamoto K, Fujisawa M et al (2025) Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes. Leukemia 39(5):1184\u20131195","journal-title":"Leukemia"},{"doi-asserted-by":"crossref","unstructured":"Ito Y, Shimono J, Kawamoto K et al (2025) TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma. Leukemia 39(7):1723\u20131734","key":"6589_CR29","DOI":"10.1038\/s41375-025-02631-5"},{"issue":"10","key":"6589_CR30","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","volume":"4","author":"NE Lewis","year":"2020","unstructured":"Lewis NE, Petrova-Drus K, Huet S et al (2020) Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv 4(10):2261\u20132271","journal-title":"Blood Adv"},{"issue":"18","key":"6589_CR31","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1182\/blood.2022015451","volume":"140","author":"M Fujisawa","year":"2022","unstructured":"Fujisawa M, Nguyen TB, Abe Y et al (2022) Clonal germinal center B cells function as a niche for T-cell lymphoma. Blood 140(18):1937\u20131950","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06589-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:30:14Z","timestamp":1761283814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06589-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6589"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06589-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review board of each participating center. The requirement for informed consent was waived because of the use of anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}